Dai Heqiao, Liu Jianying, Malkas Linda H, Catalano Jennifer, Alagharu Srilakshmi, Hickey Robert J
Department of Medicine, Hematology/Oncology Division, Indiana University School of Medicine, Indiana University Cancer Research Institute, 1044 W. Walnut Street R4-170 Indianapolis, IN 46202, USA.
Toxicol Appl Pharmacol. 2009 Apr 15;236(2):154-65. doi: 10.1016/j.taap.2008.12.028. Epub 2009 Jan 23.
Hexavalent chromium Cr(VI) is known to be a carcinogenic metal ion, with a complicated mechanism of action. It can be found within our environment in soil and water contaminated by manufacturing processes. Cr(VI) ion is readily taken up by cells, and is recognized to be both genotoxic and cytotoxic; following its reduction to the stable trivalent form of the ion, chromium(Cr(III)), within cells. This form of the ion is known to impede the activity of cellular DNA polymerase and polymerase-mediated DNA replication. Here, we report the effects of chromium on the activity and fidelity of the DNA replication process mediated by the human cell DNA synthesome. The DNA synthesome is a functional multiprotein complex that is fully competent to carry-out each phase of the DNA replication process. The IC(50) of Cr(III) toward the activity of DNA synthesome-associated DNA polymerases alpha, delta and epsilon is 15, 45 and 125 muM, respectively. Cr(III) inhibits synthesome-mediated DNA synthesis (IC(50)=88 muM), and significantly reduces the fidelity of synthesome-mediated DNA replication. The mutation frequency induced by the different concentrations of Cr(III) ion used in our assays ranges from 2-13 fold higher than that which occurs spontaneously, and the types of mutations include single nucleotide substitutions, insertions, and deletions. Single nucleotide substitutions are the predominant type of mutation, and they occur primarily at GC base-pairs. Cr(III) ion produces a lower number of transition and a higher number of transversion mutations than occur spontaneously. Unlike Cr(III), Cr(VI) ion has little effect on the in vitro DNA synthetic activity and fidelity of the DNA synthesome, but does significantly inhibit DNA synthesis in intact cells. Cell growth and proliferation is also arrested by increasing concentrations of Cr(VI) ion. Our studies provide evidence indicating that the chromium ion induced decrease in the fidelity and activity of synthesome mediated DNA replication correlates with the genotoxic and cytotoxic effects of this metal ion; and promotes cell killing via inhibition of the DNA polymerase activity mediating the DNA replication and repair processes utilized by human cells.
已知六价铬Cr(VI)是一种致癌金属离子,其作用机制复杂。在受制造过程污染的土壤和水中可发现它。Cr(VI)离子很容易被细胞摄取,并且被认为具有遗传毒性和细胞毒性;在细胞内它还原为稳定的三价离子形式铬(Cr(III))。已知这种离子形式会阻碍细胞DNA聚合酶的活性以及聚合酶介导的DNA复制。在此,我们报告铬对人细胞DNA合成体介导的DNA复制过程的活性和保真度的影响。DNA合成体是一种功能性多蛋白复合物,完全有能力执行DNA复制过程的每个阶段。Cr(III)对与DNA合成体相关的DNA聚合酶α、δ和ε活性的半数抑制浓度(IC(50))分别为15、45和125μM。Cr(III)抑制合成体介导的DNA合成(IC(50)=88μM),并显著降低合成体介导的DNA复制的保真度。我们实验中使用的不同浓度Cr(III)离子诱导的突变频率比自发发生的频率高2至13倍,突变类型包括单核苷酸替换、插入和缺失。单核苷酸替换是主要的突变类型,主要发生在GC碱基对处。与自发发生的情况相比,Cr(III)离子产生的转换突变数量较少,颠换突变数量较多。与Cr(III)不同,Cr(VI)离子对体外DNA合成活性和DNA合成体的保真度影响很小,但确实能显著抑制完整细胞中的DNA合成。细胞生长和增殖也会因Cr(VI)离子浓度增加而停止。我们的研究提供了证据表明,铬离子导致合成体介导的DNA复制保真度和活性降低与这种金属离子的遗传毒性和细胞毒性作用相关;并通过抑制介导人细胞DNA复制和修复过程的DNA聚合酶活性促进细胞死亡。